Leila Colgan Email & Phone Number

Basel, Switzerland, CH

Entrepreneurial division partnering with clinicians driving biomarker testing, through collaborative education & communication, that match timely & accurate results with the right targeted therapy at the right time within multiple solid tumor disease states. We seek to better understand the patient's "Testing Journey" and identify potential leakage points.

Murrieta, California, US

ADVISORY BOARD MEMBERServing as a Member of the Board of Directors advising on business strategy and partnership industry trends that will directly increase the effectiveness and competitiveness of Murrieta Genomics over the next five years.

San Diego, CA, US

CureMatch's Clinical Decision Support Tool uses AI Technology to assist oncologists in their cancer therapy selection. The expertly curated database matches, ranks and scores known and novel combination cancer therapies (monotherapy, 2-drug combinations and 3-drug combinations), based on the biomarkers of the patient's unique molecular tumor profile. The.

Mumbai, Maharastra, IN

• Launched SUN Pharma’s branded oncology products to KOL’s, academic centers, hospitals, and community practice oncology and urology centers within Los Angeles & Orange County
• Ranked #1 Account Manager in the Western Regional Area
• Promoted to Senior Account Manager 2021

Mission Viejo, California, US

• A key member of the Executive team to develop sales and commercial launch strategies for PEER Online Registry, a Predictive Analytics (AI) and clinical data intelligence tool to improve mental health prescription.
• Led a team of 7 national sales professionals and accelerated the sales and leadership training program assuming responsibility for $2.6M in annual revenue.
• Hired strategic reimbursement consultant resulting in 2x reimbursement.
• Restructured sales and realigned territories to position the team to return to growth and profitability.
• Expanded physician base leading to increased revenue growth of 180%.
• Implemented a strategic program called “mini-macs” to drive physician revenue, leading to 8 new revenuechannels. Increased testing orders by double digits up 107%.

San Diego, California, US

• A key member of the Sr. Leadership team to develop commercial launch strategies for disruptive ctDNA liquid biopsy testing to the oncology marketplace. Formulated business-development strategies to drive revenue growth.
• Led a team of 9 sales representatives generating $1.8M in clinical billable revenue.
• Hired, recruited, trained, coached, developed and scaled, a high-performance national sales teamsurpassing corporate testing goals by 110%.
• Recruited Chief Oncologist to provide corporate direction for research/clinical trial initiatives, new assaydevelopment, R & D gap analysis, and a national clinical advisory panel.
• Recipient of the 2015 CEO Award. Solely recognized commercial member to receive this prestigious awardfor obtaining highest revenue contributions to the organization.
• Led cross-functional teams including marketing, medical affairs, business development and R&D to drivepromotional strategies and demand of novel technology into the marketplace.Budget Development & Forecasting / P&.

• Brought on board to develop and execute strategic sales and business development initiatives related to commercialization and launch of proprietary oncology genomics technology for this startup biotechnology firm.
• Led a cross-functional team of 5, increasing revenues by 79%.
• Devised and implemented go-to-market strategy to launch ClearID, a 50-oncogene solid-tumor next-generation sequencing test for breast cancer, leading a subsequent launch of additional cancer tests anddelivering $3M in.
• Identified and steered negotiations of a new distribution partnership that enhanced portfolio reach resultingin $3.8M sales opportunity.
• Spearheaded launch of LiquidBiopsyTM platform with OEM partner and two new license opportunitiesresulting in $3.5M in sales.
• Established the “first-ever” advisory board consisting of KOLs from varying cancer specialties, resulting inadvancing 4 clinical trial discovery initiatives.

Chicago, US

• Progressed from product management responsibility to Sr. Marketing Manager with full marketing accountability for $85M molecular diagnostic solid tumor product portfolio for established healthcare subsidiary of GE.
• Delivered visionary leadership launching a $6M test KRAS (a solid tumor biomarker) earning the distinction for most successful product launch in company history.
• Leveraged KRAS launch success to roll-out an additional 30+ tests leading to a $85M genomic portfolio, with primary focus on NSCLC, colorectal, pancreatic, melanoma, breast, gastric cancers, resulting in multiple sales.
• Trained a 200+ U.S. and global employee staff and 48 sales representatives’ team in oncology.
• Strengthened existing relationship with KOL’s to negotiate and secure exclusive partnerships.

Thousand Oaks, CA, US

• Recruited to execute winning sales and account management strategy to restore profitability within second-largest ($48M) territory in Western Region for established biopharmaceutical/oncology products company.
• Turnaround and penetrated geographical sales from bottom 5% to top 10% in declining market securing top-ranking district-wide, region-wide, and nation-wide; won multiple company awards.
• Achieved exceptional market share and market growth for key products, including 100%+ market share for Aranesp, Neulasta, Vectibix and a POA execution high of 180%.
• Initiated, and cemented relationships with KOL’s, oncologists, pharmacists, hospitals, home health providers, advocates and practice managers, resulting in overall 98% market share.

New York, New York, US

• Led sales of Viracept and Rescriptor to physicians and infectious disease specialists in Orange County
• 110% to plan across all products
• Developed and executed educational messaging on FDA-regulated guidelines for HIV / AIDS treatment and maintenance prescription practices
• Tracked budget and expenses. Advised with AIDS Service Organizations (ASOs), Community Based Organizations (CBOs), and patient community
• Developed physician and pharmacy advocates specializing in HIV / AIDS medication management

Cambridge, Cambridgeshire, GB

• Marketed specialty product line, including Prilosec, Plendil, and Atacand, to client base comprised of cardiologists, pulmonologists, and nephrology pharmacists as well as internal medicine, family practice, and Tier 2.
• Highest national market share (115%) for newly launched ace inhibitor surpassing corporate expectations
• Maintained highest quarter over quarter market shares (over 100%) regionally and nationally for all existing products
• Implemented product education and exceptional client service, managing key accounts such as St. Joseph Hospital, Saddleback Memorial Hospital, Mission Hospital, Bristol Park Medical Group, Yorba Group, and the.
• Influenced fellowship programs, grand rounds, and fellow graduation events
• Guided in conferences and meetings held by GI and CV consultants, professional societies (OCGI, OCIM, and OC Endocrine), osteopathic physicians and surgeons, and the Indian Medical Association

Rahway, New Jersey, US

• Tasked with establishing a market for bone mineral density product Fosamax following the merger of Astra Merck and AstraZeneca
• Congratulated by Kaiser Permanente’s CEO for establishing 1st ever women’s health conference surpassing attendee expectations of over 350 women
• Ensure that hospitals and radiology centers have the proper equipment, such as DEXA scanners, equipment essential to the successful launch of Fosamax.
• Administered physician and consumer education programs at Kaiser, Cigna, HealthNet, FHIP, Clinica Medica General, and Chauma.
• Coached physician advocates for bone mineral density research

Abbott Park, Illinois, US

• Exceeded all product goals Depakote 112% with total Rxs at 111% and Cylert 105%.
• Added sprinkle formulation (powder-based) at Fairview Development Center & Metropolitan State Hospital.
• Represented company at many CME programs, conventions, displays
• Initiated a communication process for sales force.
• Volunteered Epilepsy Foundation, NDMDA.

Abbott Park, Illinois, US

• Exceeded all sales goals Hytrin 100%, Biaxin 107%, PCE 500 145%.
• Achieved "All Star" and District competition award - top 20% in Western Region.
• Selected as district team leader.
• Sold diagnostic equipment.
• Promoted to CNS Representative

Mba, Business

B.A., Psychology

Psychology Focus, Psychology